Mumps vaccine effectiveness in highly immunized populations

Angela Domínguez, Núria Torner, Jesús Castilla, Joan Batalla, Pere Godoy, Marcela Guevara, Dolors Carnicer, Joan Caylà, Cristina Rius, Josep Maria Jansà

Research output: Contribution to journalArticle

Abstract

The aim of the study was to investigate effectiveness of mumps MMR component in communities with high MMR coverage. Outbreak-related cases of mumps born between 1995 and 2005 notified to Navarre and Catalonia public health services during the period 2005-2007 were studied. Vaccine effectiveness (VE) and their 95%CI were calculated using the screening method. Of 47 confirmed, 85.1% immunized with at least one dose (1MMR) and 44.9% with two (2MMR). Estimated VE was 85.4% (95%CI: 67.3-93.4) for 1MMR and 88.5% (95%CI: 78.1-93.9) for 2MMR. High 2MMR coverage, improved confirmation techniques and further VE studies with all confirmed cases are needed to prevent further outbreaks.

Original languageEnglish (US)
Pages (from-to)3567-3570
Number of pages4
JournalVaccine
Volume28
Issue number20
DOIs
StatePublished - Apr 30 2010
Externally publishedYes

Fingerprint

Mumps Vaccine
Mumps
Vaccines
vaccines
Disease Outbreaks
Population
United States Public Health Service
health services
public health
screening
dosage
methodology

Keywords

  • Immunization
  • Mumps
  • Vaccine effectiveness

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

Domínguez, A., Torner, N., Castilla, J., Batalla, J., Godoy, P., Guevara, M., ... Jansà, J. M. (2010). Mumps vaccine effectiveness in highly immunized populations. Vaccine, 28(20), 3567-3570. https://doi.org/10.1016/j.vaccine.2010.02.107

Mumps vaccine effectiveness in highly immunized populations. / Domínguez, Angela; Torner, Núria; Castilla, Jesús; Batalla, Joan; Godoy, Pere; Guevara, Marcela; Carnicer, Dolors; Caylà, Joan; Rius, Cristina; Jansà, Josep Maria.

In: Vaccine, Vol. 28, No. 20, 30.04.2010, p. 3567-3570.

Research output: Contribution to journalArticle

Domínguez, A, Torner, N, Castilla, J, Batalla, J, Godoy, P, Guevara, M, Carnicer, D, Caylà, J, Rius, C & Jansà, JM 2010, 'Mumps vaccine effectiveness in highly immunized populations', Vaccine, vol. 28, no. 20, pp. 3567-3570. https://doi.org/10.1016/j.vaccine.2010.02.107
Domínguez A, Torner N, Castilla J, Batalla J, Godoy P, Guevara M et al. Mumps vaccine effectiveness in highly immunized populations. Vaccine. 2010 Apr 30;28(20):3567-3570. https://doi.org/10.1016/j.vaccine.2010.02.107
Domínguez, Angela ; Torner, Núria ; Castilla, Jesús ; Batalla, Joan ; Godoy, Pere ; Guevara, Marcela ; Carnicer, Dolors ; Caylà, Joan ; Rius, Cristina ; Jansà, Josep Maria. / Mumps vaccine effectiveness in highly immunized populations. In: Vaccine. 2010 ; Vol. 28, No. 20. pp. 3567-3570.
@article{9751a7ac4bba49bea6a8f41ee535396d,
title = "Mumps vaccine effectiveness in highly immunized populations",
abstract = "The aim of the study was to investigate effectiveness of mumps MMR component in communities with high MMR coverage. Outbreak-related cases of mumps born between 1995 and 2005 notified to Navarre and Catalonia public health services during the period 2005-2007 were studied. Vaccine effectiveness (VE) and their 95{\%}CI were calculated using the screening method. Of 47 confirmed, 85.1{\%} immunized with at least one dose (1MMR) and 44.9{\%} with two (2MMR). Estimated VE was 85.4{\%} (95{\%}CI: 67.3-93.4) for 1MMR and 88.5{\%} (95{\%}CI: 78.1-93.9) for 2MMR. High 2MMR coverage, improved confirmation techniques and further VE studies with all confirmed cases are needed to prevent further outbreaks.",
keywords = "Immunization, Mumps, Vaccine effectiveness",
author = "Angela Dom{\'i}nguez and N{\'u}ria Torner and Jes{\'u}s Castilla and Joan Batalla and Pere Godoy and Marcela Guevara and Dolors Carnicer and Joan Cayl{\`a} and Cristina Rius and Jans{\`a}, {Josep Maria}",
year = "2010",
month = "4",
day = "30",
doi = "10.1016/j.vaccine.2010.02.107",
language = "English (US)",
volume = "28",
pages = "3567--3570",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "20",

}

TY - JOUR

T1 - Mumps vaccine effectiveness in highly immunized populations

AU - Domínguez, Angela

AU - Torner, Núria

AU - Castilla, Jesús

AU - Batalla, Joan

AU - Godoy, Pere

AU - Guevara, Marcela

AU - Carnicer, Dolors

AU - Caylà, Joan

AU - Rius, Cristina

AU - Jansà, Josep Maria

PY - 2010/4/30

Y1 - 2010/4/30

N2 - The aim of the study was to investigate effectiveness of mumps MMR component in communities with high MMR coverage. Outbreak-related cases of mumps born between 1995 and 2005 notified to Navarre and Catalonia public health services during the period 2005-2007 were studied. Vaccine effectiveness (VE) and their 95%CI were calculated using the screening method. Of 47 confirmed, 85.1% immunized with at least one dose (1MMR) and 44.9% with two (2MMR). Estimated VE was 85.4% (95%CI: 67.3-93.4) for 1MMR and 88.5% (95%CI: 78.1-93.9) for 2MMR. High 2MMR coverage, improved confirmation techniques and further VE studies with all confirmed cases are needed to prevent further outbreaks.

AB - The aim of the study was to investigate effectiveness of mumps MMR component in communities with high MMR coverage. Outbreak-related cases of mumps born between 1995 and 2005 notified to Navarre and Catalonia public health services during the period 2005-2007 were studied. Vaccine effectiveness (VE) and their 95%CI were calculated using the screening method. Of 47 confirmed, 85.1% immunized with at least one dose (1MMR) and 44.9% with two (2MMR). Estimated VE was 85.4% (95%CI: 67.3-93.4) for 1MMR and 88.5% (95%CI: 78.1-93.9) for 2MMR. High 2MMR coverage, improved confirmation techniques and further VE studies with all confirmed cases are needed to prevent further outbreaks.

KW - Immunization

KW - Mumps

KW - Vaccine effectiveness

UR - http://www.scopus.com/inward/record.url?scp=77950692225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950692225&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2010.02.107

DO - 10.1016/j.vaccine.2010.02.107

M3 - Article

C2 - 20226249

AN - SCOPUS:77950692225

VL - 28

SP - 3567

EP - 3570

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 20

ER -